Journal Of Clinical Oncology (jco) Podcast
Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:10:30
- Mas informaciones
Informações:
Sinopsis
This JCO podcast provides observations and commentary on the JCO article, Survival, Durable Tumor Remission, and Long-Term Safety in Patients with Advanced Melanoma Receiving Nivolumab,” by Suzanne Topalian, et al.
